Patient Preferences Regarding Side Effects of Chemotherapy for Ovarian Cancer: Do They Change over Time?
- 1 October 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 87 (1) , 118-128
- https://doi.org/10.1006/gyno.2002.6807
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Visual Analog Scales: Do They Have a Role in the Measurement of Preferences for Health States?Medical Decision Making, 2001
- Stability of Patients' Preferences for Chemotherapy: The Impact of ExperienceMedical Decision Making, 2001
- High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term resultsBone Marrow Transplantation, 2000
- Pharmacoeconomic Considerations in Treating Ovarian CancerPharmacoEconomics, 2000
- Perceptions of Cisplatin-Related Toxicity among Ovarian Cancer Patients and Gynecologic OncologistsGynecologic Oncology, 1998
- Cost–Utility Analysis of Paclitaxel in Combination with Cisplatin for Patients with Advanced Ovarian CancerGynecologic Oncology, 1997
- Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scaleCancer Nursing, 1997
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993Annals of Oncology, 1996
- Utilities and Quality-Adjusted Life YearsInternational Journal of Technology Assessment in Health Care, 1989
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983